Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet consectetur. Integer eget magna mollis eleifend. Ullamcorper eu mauris luctus amet nullam. Feugiat mi libero lacus in ac magna turpis viverra.

Subscribe to news

We are excited to keep you updated with news tailored to your preferences.

By subscribing to one or more streams, you'll receive information relevant to the areas you've selected. If you ever wish to update your preferences, you can do so at any time.

Latest news

Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical Committees

CCO Damien Perriman and co-founder and VP of Development, Dr. Paul Opgenorth.
Read more

The challenges of SynBio

Read more

Transcript: Q2 2025 Earnings Call

Read more

eXoZymes provides second quarter 2025 update at 5PM EST today

Read more